Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system

Virology Journal

Volumn 7, Issue , 2010, Pages

  Zhou, Hongchao ^a   Yao, Guizhe ^b   Cui, Shangjin ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; POLYCLONAL ANTIBODY; PROTEIN VP2; HISTIDINE; HYBRID PROTEIN; POLYHISTIDINE; VIRUS ANTIGEN; VP2 PROTEIN, PORCINE PARVOVIRUS;

ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; COLUMN CHROMATOGRAPHY; ELECTRON MICROSCOPY; NONHUMAN; PORCINE PARVOVIRUS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; WESTERN BLOTTING; ANIMAL; ARMYWORM; BACULOVIRUS; CELL LINE; CYTOLOGY; GENE EXPRESSION; GENETICS; HEMAGGLUTINATION TEST; ISOLATION AND PURIFICATION; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS;

HEXAPODA; MIRIDAE; PORCINE PARVOVIRUS;

ANIMALS; ANTIGENS, VIRAL; BACULOVIRIDAE; BLOTTING, WESTERN; CAPSID PROTEINS; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; HEMAGGLUTINATION TESTS; HISTIDINE; PARVOVIRUS, PORCINE; PLASMIDS; RECOMBINANT FUSION PROTEINS; SPODOPTERA;

EID: 78751653916     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-366     Document Type: Article

References (23)

1. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. P Rueda J Fominaya JP Langeveld C Bruschke C Vela JI Casal, Vaccine 2000 19 726 734 10.1016/S0264-410X(00)00259-0 11115693
2. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. GM Allan S Kennedy F McNeilly JC Foster JA Ellis SJ Krakowka BM Meehan BM Adair, Pathol 1999 1 1 11
3. Viral Wasting Syndrome of Swine: Experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with Porcine Circovirus 2 and Porcine Parvovirus. S Krakowka JA Ellis B Meehan S Kennedy F McNeilly G Allan, Vet Pathol 2000 37 254 263 10.1354/vp.37-3-254 10810990
4. Porcine circovirus diseases. J Segales GM Allan M Domingo, Anim Health Res Rev 2005 6 119 42 10.1079/AHR2005106 16583778
5. Financial evaluation of vaccination and testing alternatives for control of parvovirus-induced reproductive failure in swine. IA Gardner TE Carpenter L Leontides TD Parsons, J Am Vet Med Assoc 1996 208 863 869 8617643
6. An economic assessment of porcine parvovirus vaccination. CR Parke GW Burgess, Aust Vet J 1993 70 177 180 10.1111/j.1751-0813.1993.tb06124.x 8393655
7. Production of porcine parvovirus empty capsids with high immunogenic activity. C Martinez K Dalsgaard JAL de Turiso E Cortes Velac JI Casal, Vaccine 1992 10 10 684 90 10.1016/0264-410X(92)90090-7 1523879
8. Mapping the antigenic structure of porcine parvovirus at the level of peptides. S Kamstrup J Langeveld A Botner,, et al. Virus Res 1998 53 163 73 10.1016/S0168-1702(97)00145-7 9620208
9. [Expression of porcine parvovirus vp2 gene and construction of virus like particles (Chinese)]. Y-h Si M-g Fang H-z Wang, Virologica Sinica 2006 21 148 152
10. Genome organization of the Kresse strain of porcine parvovirus: identification of the allotropic determinant and comparison with those of NADL-2 and field isolates. J Bergeron B Hebert P Tijssen, J Virol 1996 70 4 2508 15 8642680
11. Crystal Structure of Insecticidal d-Endotoxin from Bacillus thuringiensis at 2.5 resolutions. J Li J Carroll DJ Ellar, Nature 1991 353 6347 815 821 10.1038/353815a0 1658659
12. Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. U Truyen CR Parrish, J Virol 1992 66 9 5399 408 1323703
13. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2. Q Pan K He K Huang, Vaccine 2008 26 17 2119 26 18378364
14. Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. L Maranga TF Brazao MJ Carrondo, Biotechnology and Bioengineering 2003 84 245 253 10.1002/bit.10773 12966582
15. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. VA Luckow VA Luckow SC Lee GF Barry PO Olins, J Virol 1993 67 8 4566 79 8392598
16. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells. PO Michel AR Mäkelä E Korhonen J Toivola L Hedman M Söderlund-Venermo K Hedman CJ Oker-Blom, J Virol Methods 2008 152 1-2 1 5 10.1016/j.jviromet.2008.06.006 18598721
17. Expression of porcine parvovirus VP2 gene requires codon optimized E. T Qi S Cui, coli cells Virus Genes 2009
18. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant. R Lo-Man P Rueda C Sedlik E Deriaud I Casal C Leclerc, Eur J Immunol 1998 28 4 1401 7 10.1002/(SICI)1521-4141(199804)28:04<1401::AID-IMMU14013.0. CO;2-M 9565380
19. Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography. YC Hu WE Bentley GH Edwards VN Vakharia, Biotechnol Bioeng 1999 63 6 721 9 10.1002/(SICI)1097-0290(19990620)63:6<721::AID-BIT103.0.CO;2-O 10397829
20. An improved hemagglutination test for study of canine parvovirus Vet. M Senda N Hirayama H Yamamoto K Kurata, Microbio 1986 12 1 1 6
21. Use of parvovirus-like particles for vaccination andinduction of multiple immune responses. JI Casal, Biotechnol Appl Biochem 1999 29 141 150 10075910
22. Parvovirus diagnostic and vaccine production in insect cells. JI Casal, Cytotechnology 1996 20 261 270 10.1007/BF00350405
23. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. AFG Antonis CJM Bruschke R Paloma L Maranga JI Casal C Vela LAT Hilgers PBGM Belt K Weerdmeester MJT Carrondo JPM Langeveld, Vaccine 2006 24 5481 5490 10.1016/j.vaccine.2006.03.089 16730104